By InvitationNot Applicable

Prevalence of Advanced Fibrosis in Patients Living With HIV

Germany300 participantsStarted 2018-10-01

Plain-language summary

Monocentric, cross-sectional study to define the prevalence of advanced fibrosis in an HIV infected outpatient population. Follow-up over 10 years to assess clinical relevance.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * informed consent * age \>18 Exclusion Criteria: * pregnancy * disease with expectation of life under 12 months

What they're measuring

Prevalence of significant hepatic fibrosis

Timeframe: 1 year

Trial details

NCT IDNCT04066608

SponsorJohannes Gutenberg University Mainz

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-10-01

View on ClinicalTrials.gov More Fatty Liver Disease trials